Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 5/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15937285 | 1.00 | ALOX5 (0.34) | ALOX5PGRKMT2AMEN1KDM4E | |
| SCHEMBL15937361 | 0.99 | ALOX5 (0.35) | ALOX5PGRKMT2AMEN1KDM4E | |
| SCHEMBL17717542 | 0.91 | PGR (0.32) | ALOX5PGRKMT2AMEN1MAPT | |
| SCHEMBL15937278 | 0.85 | ALOX5 (0.47) | ALOX5 | |
| SCHEMBL13371826 | 0.83 | ALOX5 (0.48) | ALOX5PGRKMT2AMEN1 | |
| SCHEMBL13371849 | 0.82 | ALOX5 (0.48) | ALOX5PGRMAPT | |
| SCHEMBL15937281 | 0.81 | ALOX5 (0.50) | ALOX5MAPT | |
| SCHEMBL15937342 | 0.81 | ALOX5 (0.35) | ALOX5PGRKMT2AMEN1KDM4E | |
| SCHEMBL15937337 | 0.80 | ALOX5 (0.34) | ALOX5PGRKMT2AMEN1KDM4E | |
| SCHEMBL15937365 | 0.80 | ALOX5 (0.34) | ALOX5PGRKMT2AMEN1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160126476-A1 | NOVEL COMPOUND, LIGHT EMITTING DEVICE COMPRISING SAME, AND ELECTRONIC DEVICE | LMS CO., LTD. (KR) | 2016-05-05 | — | — | US | disclosed |
| US-20160126476-A1 | NOVEL COMPOUND, LIGHT EMITTING DEVICE COMPRISING SAME, AND ELECTRONIC DEVICE | LMS CO., LTD. (KR) | 2016-05-05 | — | — | US | disclosed |
| WO-2014119895-A1 | NOVEL COMPOUND, LIGHT EMITTING DEVICE COMPRISING SAME, AND ELECTRONIC DEVICE | 주식회사 엘엠에스 (KR) | 2014-08-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160126476-A1 | NOVEL COMPOUND, LIGHT EMITTING DEVICE COMPRISING SAME, AND ELECTRONIC DEVICE | ELAVL1, SUN2, PER2 | ALOX5 640/4885PGR 3029/4885KMT2A 2131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.